Science that is transforming lives and enabling the future

Entegris and Agilitech: Transforming Single-Use Technologies

All Posts

Entegris and Agilitech: Transforming Single-Use Technologies

Entegris is delighted to announce our collaboration with Agilitech, a pioneering partner to the biotech industry. Agilitech provides highly flexible, scalable, and future-proof single-use technologies for every step of the bioprocess. These include chromatography systems, mixers, and custom-tailored bioprocess controllers that scale from the laboratory to commercial production environments. This makes them a natural fit for the unique needs of life sciences customers.

“In the bioprocessing market, the process is the product. Agilitech’s focus on meeting the customer’s process needs lines up well with the Entegris approach, which involves offering customer configured solutions to better serve the market,” said Todd Kapp, Global Commercial Development Director, Life Sciences, Entegris.


Our collaboration with Agilitech allows us to offer an extended line of custom, single-use systems for cell and gene therapies. With them, we can deliver flexible technologies that accelerate speed-to-market, optimize yield, and maintain high purity. The Agilitech partnership offers customers a complete, end-to-end solution for all bioproduction needs, including both upstream and downstream solutions.

“Our partnership with Entegris dovetails perfectly with the end-to-end bioprocess solutions we offer at Agilitech, as both companies specialize in providing flexible and customizable single-use solutions for bioprocessing,” said Phil Sanders, Biotech Chief Innovation Officer, Agilitech. “By combining our expertise, we have the ability to design tailored solutions in a safe and speedy manner, delivering additional value to our customers.”

Entegris is proud to deliver technology solutions to help solve multifaceted cell and gene therapy requirements through our portfolio of single-use products.

Visit our microsite for more information on our cell and gene therapy solutions.


Related Posts

Critical Factors in Achieving a Strong Supply Chain for Your Cell and Gene Therapy

Are you looking for a supply partner to help you scale cell and gene therapy (CGT) manufacturing? Do you need a partner that can help you keep up with pre-existing capacity increases? These challenges may lead to some hard choices.

Automotive Reliability and Semiconductor Manufacturing: How Far Did We Come?

Last year, Semiconductor Digest assembled six panelists from the world's leading semiconductor and automotive manufacturers and suppliers - including Volkswagen, Texas Instruments, Robert Bosch, Hyperion, and KLA, and Entegris - and asked them about the state of automotive electronics. They discussed issues such as the shift to automotive quad computing, the emphasis on infotainment, and the rise of alternative vehicle technologies such as electrification and self-driving.

Entegris and Qosina: Expediting Single-use Bioprocess Solutions Together

Have you ever needed to perform a test only to be held up by wait times for a single-use component? Perhaps you just need a small order of tubing or connectors, without everything that comes with a bulk order? We want to help customers get the right quantity of components when they need them. That’s why Entegris is proud to announce a new relationship with Qosina, a leading global supplier of OEM single-use components to the medical and pharmaceutical industries.